Chemical Structure (Oxybutynin 01)
Oxybutynin Chloride Tablet
Product Images NDC 0832-0038
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 0832-0038). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Oxybutynin 02)
Figure 2 (Oxybutynin 03)
Principal Display Panel (5 mg Tablet Blister Pack Carton)
Oxybutynin Chloride is a medication available in tablet form. Each tablet contains 5mg of the active ingredient. This package contains 100 tablets in unit-dose packaging. The recommended dosage is described in the package insert. Storage instructions indicate that this medication should be kept at 20°C to 25°C. The package is designed for institutional use only and is not child-resistant. It should not be used in households and should be kept out of the reach of children. The package is manufactured by Upsher-Smith Laboratories in Minnesota.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
